Related Experiment Video
Updated: Jun 19, 2026

Evidence-based Knowledge Synthesis and Hypothesis Validation: Navigating Biomedical Knowledge Bases via Explainable AI and Agentic Systems
Published on: June 13, 2025
Is evidence sufficient for evidence-based medicine?
1Department of Psychiatry, Ludwig-Maximilians-University, Nussbaumstrasse 7, 80336 Munich, Germany. hans-juergen.moeller@med.uni-muenchen.de
Evidence-based medicine (EBM) aims to regulate psychopharmacotherapy, but challenges remain in defining evidence standards and integrating diverse study types. Complex clinical decisions still heavily rely on clinical experience alongside research findings.
Area of Science:
- Psychiatry
- Clinical Pharmacology
- Evidence-Based Medicine
Background:
- Psychopharmacotherapy is increasingly expected to align with evidence-based medicine (EBM) principles.
- This shift aims to improve routine psychiatric healthcare but presents implementation challenges.
- Current EBM approaches face difficulties in establishing universally accepted evidence hierarchies.
Purpose of the Study:
- To examine the application and limitations of evidence-based medicine (EBM) in psychopharmacotherapy.
- To discuss the sufficiency of phase III trial data for EBM in psychiatry.
- To explore the role of clinical experience in complex psychopharmacotherapy decision-making.
Main Methods:
- Analysis of the principles and challenges of applying evidence-based medicine (EBM) to psychopharmacotherapy.
- Discussion on the limitations of generalizing findings from phase III trials.
- Consideration of evidence from effectiveness studies and phase IV trials.
Main Results:
- Consensus on international evidence grading for psychopharmacotherapy remains elusive.
- Phase III trials, while having high internal validity, have limitations in generalizability.
- Complex clinical decisions in psychopharmacotherapy often depend on clinical experience, traditions, and belief systems, more than on published study results.
Conclusions:
- Regulating psychopharmacotherapy with evidence-based medicine (EBM) is beneficial but requires broader evidence sources beyond phase III trials.
- Effectiveness studies and phase IV trials are crucial for complementing efficacy data.
- Despite EBM advancements, clinical experience remains a significant factor in complex psychopharmacotherapy decisions.
Related Concept Videos
Methods of Documentation V: CBE
In CBE, healthcare professionals establish predefined standards of practice that define what constitutes...
The Evidence for Evolution
Bioequivalence of Drugs: Drugs with Multiple Indications
Introduction to Documentation and Reporting
Nursing documentation records essential information and details regarding a patient's care and treatment in written or electronic form. It is a critical aspect of nursing practice that involves documenting assessments, interventions, outcomes, and other relevant details about a patient's health status.
Documentation maps the patient's health journey by creating a comprehensive and precise...
Hazard Ratio
For example, in a clinical trial evaluating a...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...